About Covalent Laboratories
Covalent Laboratories is a company based in Hyderabad (India) founded in 2002 by Narayana Reddy. It operates as a B2B. The company has 815 employees as of March 31, 2023. Covalent Laboratories offers products and services including Cefixime, Cefdinir, and Cefprozil. Covalent Laboratories operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 815 as on 31 Mar, 2023
- Founders Narayana Reddy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Covalent Laboratories Private Limited
- Date of Incorporation 13 Sep, 2002
- Jurisdiction Hyderabad., Telangana, India
-
Annual Revenue
$267.64 M (USD)22.81as on Mar 31, 2023
-
Net Profit
$4.21 M (USD)-33.26as on Mar 31, 2023
-
EBITDA
$9.61 M (USD)-18.34as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
815
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Covalent Laboratories
Covalent Laboratories offers a comprehensive portfolio of products and services, including Cefixime, Cefdinir, and Cefprozil.
Antibiotic active pharmaceutical ingredient for treating infections
Cephalosporin antibiotic for bacterial infection treatment
Oral cephalosporin antibiotic for various infections
Funding Insights of Covalent Laboratories
Detailed funding history for Covalent Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Covalent Laboratories
Investment portfolio details for Covalent Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Covalent Laboratories
Detailed financials for Covalent Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Covalent Laboratories Comparisons
Peer comparison for Covalent Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Covalent Laboratories
Covalent Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Covalent Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Covalent Laboratories
Complete news archive for Covalent Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Covalent Laboratories
Covalent Laboratories was founded in 2002.
Covalent Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Covalent Laboratories is 815.
Annual revenue of Covalent Laboratories is $267.64M as on Mar 31, 2023.
Covalent Laboratories Private Limited is a certified manufacturer of Active Pharmaceutical Ingredients, focusing on Cephalosporins and intermediates. Based in Hyderabad, India, it operates advanced facilities to produce high-quality APIs that meet international standards like USP and BP. The company serves regulated and semi-regulated markets globally through bulk manufacturing and process development, emphasizing cost reduction and quality control in its operations.
Covalent Laboratories's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Covalent Laboratories offers Cefixime, Cefdinir, and Cefprozil.